134 related articles for article (PubMed ID: 18579402)
1. Fatal thrombosis with activated factor VII in a paediatric patient on extracorporeal membrane oxygenation.
Chalwin RP; Tiruvoipati R; Peek GJ
Eur J Cardiothorac Surg; 2008 Sep; 34(3):685-6. PubMed ID: 18579402
[TBL] [Abstract][Full Text] [Related]
2. Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation.
Niebler RA; Punzalan RC; Marchan M; Lankiewicz MW
Pediatr Crit Care Med; 2010 Jan; 11(1):98-102. PubMed ID: 19561557
[TBL] [Abstract][Full Text] [Related]
3. Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery.
Wittenstein B; Ng C; Ravn H; Goldman A
Pediatr Crit Care Med; 2005 Jul; 6(4):473-6. PubMed ID: 15982438
[TBL] [Abstract][Full Text] [Related]
4. Activated recombinant factor VII and extracorporeal membrane oxygenation: everything is all right, nothing is wrong?
Dominguez TE; Brown KL
Pediatr Crit Care Med; 2010 Jan; 11(1):155-6. PubMed ID: 20051799
[No Abstract] [Full Text] [Related]
5. Safety and efficacy of recombinant activated factor VII for refractory hemorrhage in pediatric patients on extracorporeal membrane oxygenation: a single center review.
Long MT; Wagner D; Maslach-Hubbard A; Pasko DA; Baldridge P; Annich GM
Perfusion; 2014 Mar; 29(2):163-70. PubMed ID: 23942787
[TBL] [Abstract][Full Text] [Related]
6. Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation.
Verrijckt A; Proulx F; Morneau S; Vobecky S
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1812-3. PubMed ID: 15173742
[No Abstract] [Full Text] [Related]
7. Fatal outcome of recombinant factor VIIa in heart transplantation with extracorporeal membrane oxygenation.
Syburra T; Lachat M; Genoni M; Wilhelm MJ
Ann Thorac Surg; 2010 May; 89(5):1643-5. PubMed ID: 20417801
[TBL] [Abstract][Full Text] [Related]
8. Fatal Thrombosis After Factor VII Administration During Extracorporeal Membrane Oxygenation.
Swaminathan M; Shaw AD; Greenfield RA; Grichnik KP
J Cardiothorac Vasc Anesth; 2008 Apr; 22(2):259-60. PubMed ID: 18375330
[No Abstract] [Full Text] [Related]
9. Successful use of recombinant factor VIIa in a patient with intractable bleeding during extracorporeal membrane oxygenation.
Brose S; Sirbu H; Engel M; Kuhlen R; Autschbach R
Thorac Cardiovasc Surg; 2005 Dec; 53(6):389-90. PubMed ID: 16311981
[TBL] [Abstract][Full Text] [Related]
10. Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII.
Bui JD; Despotis GD; Trulock EP; Patterson GA; Goodnough LT
J Thorac Cardiovasc Surg; 2002 Oct; 124(4):852-4. PubMed ID: 12324751
[No Abstract] [Full Text] [Related]
11. Recombinant human activated factor VII is thrombogenic in a rabbit model of cyclic flow reduction and does not reduce intra-abdominal bleeding.
Charbonneau S; Girard F; Boudreault D; Ruel M; Blais N; Hardy JF
Thromb Haemost; 2007 Feb; 97(2):296-303. PubMed ID: 17264960
[TBL] [Abstract][Full Text] [Related]
12. Fatal thrombotic event after infusion of recombinant activated factor VII after cardiac surgery.
Pichon N; Bellec F; Sekkal S; Marsaud JP; Laskar M; François B; Vignon P
J Thorac Cardiovasc Surg; 2008 Jul; 136(1):220-1. PubMed ID: 18603082
[No Abstract] [Full Text] [Related]
13. Use of recombinant activated factor VII in children.
Hammer GB; Williams GD
Paediatr Anaesth; 2007 Dec; 17(12):1123-5. PubMed ID: 17986029
[No Abstract] [Full Text] [Related]
14. Relative risks of recombinant factor VII.
McMullan DM
Pediatr Crit Care Med; 2009 Sep; 10(5):604-5. PubMed ID: 19741450
[No Abstract] [Full Text] [Related]
15. rFV11a and paediatric open-heart surgery: thrombosis in the cardiopulmonary bypass circuit in spite of adequate markers of anticoagulation.
Chambers NA; Andrews D; Frew E; Kelly R; Cole C
Anaesthesia; 2009 Jun; 64(6):683-6. PubMed ID: 19453324
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of rituximab in acquired factor XIII inhibitor after arterial rFVIIa-induced thrombosis.
Ngo Sack F; Galinat H; Egreteau PY; Mollard LM; Fortin H; Berthou C; Abgrall JF; Pan-Petesch B
Haemophilia; 2013 Mar; 19(2):e93-4. PubMed ID: 23205641
[No Abstract] [Full Text] [Related]
17. Successful use of factor VIIa to control life-threatening post-operative haemorrhage in a patient on extra-corporeal membrane oxygenation.
Dunne B; Xiao P; Andrews D
Heart Lung Circ; 2012 Apr; 21(4):229-30. PubMed ID: 22036715
[TBL] [Abstract][Full Text] [Related]
18. Use of recombinant factor VIIa (Novoseven) in combination with other coagulation products led to a thrombotic occlusion of the truncus brachiocephalicus in a neonate supported by extracorporal membrane oxygenation.
Velik-Salchner C; Sergi C; Fries D; Moser P; Streif W; Kolbitsch C
Anesth Analg; 2005 Sep; 101(3):924. PubMed ID: 16116021
[No Abstract] [Full Text] [Related]
19. Recombinant activated factor VII in cardiac surgery--will we ever know for sure?
Silver DA; D'Ambra MN
Crit Care Med; 2007 Jul; 35(7):1782-3. PubMed ID: 17581365
[No Abstract] [Full Text] [Related]
20. Thrombosis associated with the use of recombinant activated factor VII: profiling two events.
Ng HJ; Loh SM; Tan DC; Lee LH
Thromb Haemost; 2004 Dec; 92(6):1448-9. PubMed ID: 15624250
[No Abstract] [Full Text] [Related]
[Next] [New Search]
